A multidisciplinary quality improvement project to improve the safety of oral chemotherapy in hospitalized patients.

Authors

null

R. Alejandro Sica

University of Illinois at Chicago, Chicago, IL

R. Alejandro Sica, Amer Sidani, Gelenis Calzadilla Domingo, Diana Sullivan, Katherine Sencion, Dominic Ho, Christina Haaf, Adam Bursua, Neeta K. Venepalli

Organizations

University of Illinois at Chicago, Chicago, IL, University of Illinois at Chicago Medical Center, Chicago, IL

Research Funding

No funding sources reported

Background: At the University of Illinois Hospital and Health Sciences System (UIC), inpatient IV chemotherapy administration occurs in the setting of specific protocols and multidisciplinary safety assessments while oral chemotherapy agent (OCA) inpatient administration occurs less formally. Baseline 8 week review of 174 admissions to the oncology service revealed that of 16 patients (9.2%) on outpatient OCA, 50% received OCAs while inpatient, with 12. 55% having a formal chemotherapy note in place. We aimed to increase the percentage of administered OCAs with associated provider generated chemotherapy notes from 12.5% to 75% over 16 weeks. Methods: A multidisciplinary task force comprised of oncology providers, clinical pharmacy, nursing leadership, and information technology was assembled. An actual and ideal process map was created, and using tools such as affinity sorting and root cause analysis, interventions were implemented focusing on residents (knowledge of OCA), nurses (documentation and policy adherence), pharmacists (education, policy adherence) and IT team (order modification). A standardized multidisciplinary hospital wide process was implemented for OCA ordering, administration, documentation, and patient education. A novel REDCap (research electronic data capture) auditing procedure was designed by which a weekly pharmacy report of every oral chemotherapy order at UI Health is automatically generated. Results: Between June and September 2015, a total of 67 OCA administration reports were audited. OCA notes were associated with OCA administration in 58% of cases in June, 100% in July, 78% in August and 93% in September. Furthermore, OCA notes were entered within 4 hours of OCA ordering in 58% of cases in June, 54% in July and 78% of the cases in August and September. No adverse events were reported. Conclusions: At the University of Illinois Hospital and Health Sciences System, a multidisciplinary team designed and implemented a standardized OCA administration, ordering, and documentation process focused on safe, appropriate and timely inpatient OCA administration. A novel REDCap auditing process assisted the team to identify the areas in need of optimization.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Practice of Quality and Cost, Value, and Policy in Quality

Track

Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality

Sub Track

Learning from Projects Done in a Health System

Citation

J Clin Oncol 34, 2016 (suppl 7S; abstr 110)

DOI

10.1200/jco.2016.34.7_suppl.110

Abstract #

110

Poster Bd #

K5

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Safe and reliable inpatient chemotherapy administration: Impact of an ambulatory oncology pharmacist.

First Author: Mary Yousef

First Author: Julia R. Trosman

First Author: Luluh Bin Dayil

First Author: Manish A. Shah